Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine immunological effects during laparoscopic cholecystectomy
RBR-2rgxbdvPhase 3Completed
- Sponsor
- Gustavo Nascimento Silva
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial comparing Sevoflurane + dexmedetomidine with Sevoflurane + placebo (2 arms). Primary endpoint: Immunological reactions. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on RBR-2rgxbdv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2rgxbdv.